Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» IGI Laboratories has acquired the rights to 15 drugs from AstraZeneca's injectable business in deal worth close to $9.5 million
IGI Laboratories has acquired the rights to 15 drugs from AstraZeneca's injectable business in deal worth close to $9.5 million
IGI Laboratories has acquired the rights to 15 drugs from AstraZeneca's injectable business in deal worth close to $9.5 million
Submitted by
admin
on September 26, 2014 - 9:14am
Source:
Bidness Etc.
News Tags:
IGI
AstraZeneca
injectables
Headline:
IGI Laboratories has acquired the rights to 15 drugs from AstraZeneca's injectable business in deal worth close to $9.5 million
Do Not Allow Advertisers to Use My Personal information